Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.
According to Baxter's latest financial reports the company's current EPS (TTM) is โน437.29. In 2022 the company made an earnings per share (EPS) of -โน412.53 a decrease over its 2021 EPS that were of โน218.65.
Year | EPS | Change |
---|---|---|
2023 (TTM) | โน425.93 | -203.25% |
2022 | -โน412.53 | -288.67% |
2021 | โน218.65 | 18.52% |
2020 | โน184.48 | 10.2% |
2019 | โน167.40 | -34.45% |
2018 | โน255.37 | 126.52% |
2017 | โน112.74 | -85.45% |
2016 | โน774.66 | 411.9% |
2015 | โน151.33 | -61.48% |
2014 | โน392.88 | 24.32% |
2013 | โน316.01 | -12.32% |
2012 | โน360.43 | 7.93% |
2011 | โน333.95 | 61.57% |
2010 | โน206.69 | -33.52% |
2009 | โน310.89 | 12.69% |
2008 | โน275.87 | 21.89% |
2007 | โน226.33 | 23.26% |
2006 | โน183.63 | 38.71% |
2005 | โน132.38 | 146.03% |
2004 | โน53.81 | -58% |
2003 | โน128.11 | 17.8% |
2002 | โน108.75 | 12.19% |
2001 | โน96.94 | -11.67% |
2000 | โน109.75 | -6.55% |
1999 | โน117.44 | 141.23% |
1998 | โน48.68 | 7.55% |
1997 | โน45.27 | -42.55% |
1996 | โน78.79 |